Markel Group saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, rising from 70 to 74.
IBD's proprietary RS Rating tracks technical performance by showing how a stock's price action over the last 52 weeks compares to that of the other stocks in our database.
Over 100 years of market history shows that the top-performing stocks often have an 80 or higher RS Rating in the early stages of their moves. See if Markel Group can continue to rebound and hit that benchmark.
Can You Really Time The Stock Market?
Markel Group has risen more than 5% past a 1,660.74 entry in a first-stage flat base, meaning it's now out of a proper buy zone. Look for the stock to create a new chance to get in like a three-weeks tight or pullback to the 50-day or 10-week moving average.
Top and bottom line growth moved higher last quarter. Earnings were up 2,010%, compared to -63% in the prior report. Revenue increased from -11% to 37%.
The company holds the No. 41 rank among its peers in the Insurance-Property/Casualty/Title industry group. Mercury General, Kinsale Capital Group and Allstate are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
